banner add

FDA Issues Warning of Cancer Risk Tied to CAR-T Therapies

The agency has reviewed reports of cancer patients whose treatments resulted in the development of secondary blood cancers. Several companies will be required to carry the new warning.

from NYT > Health https://ift.tt/z1xa53B
via IFTTT

No comments

China’s Rise in Drug Development Looms Over U.S.

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is ...

Theme images by PLAINVIEW. Powered by Blogger.